WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, will participate in the Citizens Life Sciences Conference in New York on May 7, 2025.
At 11:00 a.m. ET, Kris Vaddi, Ph.D., CEO, Jane Huang, M.D., President and CMO, and Peggy Scherle, Ph.D., CSO, will join a fireside chat.
A live webcast will be available on the Company’s website under Events and Presentations and will remain archived for 90 days.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.